SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and ...

Volta Labs and Ginkgo Bioworks (DNA) announced the integration of the Callisto Sample Prep System at Ginkgo Bioworks as part of the routine ...

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a value of USD 35.8 Billion by 2030 at a CAGR (Compound Annual Growth Rate) of 11 ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, expectations were $0.92. Operator: Good day, ladies and gentlemen, and ...

Illumina Inc (NASDAQ:ILMN). reported stronger-than-expected earnings for the fourth quarter of 2024, with both earnings per share (EPS) and revenue surpassing analysts' forecasts. Despite the positive ...

(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...

Meanwhile, it doesn't seem coincidental that Illumina, which is the most significant genetic sequencing business in the world, has a large Chinese rival in biotech BGI Genomics. Ever feel like you ...

More information about the trail leading up to this landmark can be found at utah.com/hiking/donut-falls These are specified with the assembler paramater. If Illumina ...

Both reverse and forward genetics in mice are currently gaining momentum through advances in next generation sequencing. Methodologies to analyse ... We present novel tools and workflows for the ...